OnabotulinumtoxinA (BOTOX®)

DRUG2 trials

Sponsors

Naval Medical Center Camp Lejeune, The Methodist Hospital Research Institute

Conditions

Chronic MigraineProstate Cancer

Phase 1

Neoadjuvant Intraprostatic OnabotulinumtoxinA Before Radical Prostatectomy for High-Risk Localized Prostate Cancer

Not yet recruitingNCT07796490

The Methodist Hospital Research InstituteProstate Cancer

Start: 2026-11-01End: 2029-11-01Target: 30Updated: 2026-09-02

Phase 3

BOTOX® vs. XEOMIN® for Chronic Migraine

RecruitingNCT05598723

Naval Medical Center Camp LejeuneChronic Migraine

Start: 2023-02-24End: 2027-08-24Target: 128Updated: 2026-07-22